509S troke is the second leading cause of death worldwide and the third most common cause of disability-adjusted lifeyears.1,2 Although stroke has an acute onset, there is abundant evidence for a long subclinical period in which cerebrovascular pathology accumulates and can be visualized on noninvasive brain imaging. Markers of subclinical cerebrovascular pathology that are known to increase the risk of ischemic stroke are white matter lesions and lacunes. 3 In the past decade, punctuate hemorrhagic lesions in the brain parenchyma, so-called cerebral microbleeds, have emerged as another manifestation of subclinical cerebrovascular pathology. 4 In contrast to white matter lesions and lacunes, microbleeds are thought to reflect the presence of both ischemic and hemorrhagic brain vasculopathy. 5,6 In addition, evidence suggests that the location of cerebral microbleeds provides more information on the type of underlying vasculopathy, ie, cerebral amyloid angiopathy (CAA) in the presence of lobar microbleeds and hypertensive arteriopathy when deep or mixed microbleeds are seen. 4,7,8
Editorial see p 479 Clinical Perspective on p 516There is a growing need to clarify whether microbleed presence indicates an increased risk of stroke, because this may provide new insights in the link between subclinical cerebrovascular pathology and stroke. So far, it is known that in patients with a history of stroke microbleed presence increases the risk of recurrent stroke, either hemorrhagic or ischemic. [9][10][11][12][13][14][15][16][17][18] Whether microbleeds are associated with an increased risk of stroke in community-dwelling elderly without a history of stroke remains unclear. Only 2 prospective studies investigated the association of microbleeds with subsequent stroke in people without a history of cerebrovascular events. 19,20 Both studies found thatBackground-Cerebral microbleeds are highly prevalent in people with clinically manifest cerebrovascular disease and have been shown to increase the risk of stroke recurrence. Microbleeds are also frequently found in healthy elderly, a population in which the clinical implication of microbleeds is unknown. Methods and Results-In the population-based Rotterdam Study, the presence, number, and location of microbleeds were assessed at baseline on brain MRI of 4759 participants aged ≥45 years. Participants were followed for incident stroke throughout the study period (2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013). We used Cox proportional hazards to investigate if people with microbleeds were at increased risk of stroke in comparison with those without microbleeds, adjusting for demographic, genetic, and cardiovascular risk, and cerebrovascular imaging markers. Microbleed prevalence was 18.7% (median count 1 In the population-based Rotterdam Study, we investigated whether cerebral microbleeds at various locations are associated with an increased risk of recurrent and first-ever ischemic stroke and intracerebral hemorrhage.
Methods
Study PopulationThe Rotterdam Study ...